Phase III trial shows donidalorsen cuts attack rate in hereditary angioedema retrieved 4 June 2024 from https://medicalxpress.com/news/2024-06-phase-iii-trial-donidalorsen-hereditary.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Doctors develop minimally invasive procedure to avoid drilling a 'burr hole' in the skull to treat clot on the brain
Doctors develop minimally invasive procedure to avoid drilling a 'burr hole' in the skull to treat clot on the brainStudy: High excess death rates in the West for 3 years running since start of pandemic despite containment and vaccinesStudy: High excess death rates in the West for 3 years running since start of pandemic despite containment and vaccinesUse this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.